Startups
Aizen Therapeutics
Aizen Therapeutics is an AI-native biotechnology company developing oral peptide medicines for chronic immune disorders. Its DaX platform uses computational protein design to create peptides with non-canonical amino acids, including D-amino acids that form mirror-image peptides. The company is advancing gut-restricted and systemic oral biologics and collaborates with biopharmaceutical partners on peptide discovery, delivery and signaling challenges. Its technology originated in David Van Valen’s laboratory at Caltech, and the company is based in San Diego.